Nanotechnology plays an undeniable significant role in medical sciences, particularly in the
field of biomedicine. Development of several diagnostic procedures in medicine has been …

Growing cancer incidence and mortality worldwide demands development of accurate
biomarkers to perfect detection, diagnosis, prognostication and monitoring. Urologic …

Renal cell carcinoma (RCC) is characterized by an infrequent number of somatic mutations.
By contrast, epigenetic aberrations are commonly found in RCC, indicating that epigenetic …

Long non-coding RNA HOTAIR was regarded as an oncogene in multiple cancers. Previous
studies have shown that HOTAIR is involved in the proliferation and tumorigenesis of renal …

The role of microRNAs (miRNAs) in cancer development was implicated as oncogene or
tumor suppressor. One of the miRNA family, the miR-200 family, was mainly characterized …

Background The rising incidence of renal cell carcinomas (RCC) constitutes a significant
challenge owing to risk of overtreatment. Because aberrant microRNA (miR) promoter …

Ovarian cancer (OC) is the most lethal gynecological malignancy. Its insidious nature,
manifesting with little to no symptoms until the disease progresses to metastasis, along with …

Despite recent advances in the understanding of the biology of renal cell carcinoma (RCC),
successful surgical treatment and implementation of novel‑targeted therapies, the prognosis …

Simple Summary Early detection of renal cell carcinoma (RCC) significantly increases the
likelihood of curative treatment, avoiding the need of adjuvant therapies, associated side …

To identify a robust panel of microRNA (miRNA) signatures that can distinguish renal cell
carcinoma (RCC) from normal kidney using miRNA expression levels. We performed a …